Alexion

Alexion is a global biopharmaceutical company dedicated to transforming the lives of people with rare disorders. With a strong commitment to addressing health inequities in the rare disease community, Alexion focuses on developing life-changing therapies. They offer a range of support services and medications for various rare conditions, such as aHUS, gMG, HPP, LAL-D, NMOSD, and PNH.

These medicines have made a significant impact on patients' lives, allowing them to live their best lives and pursue their dreams. In addition to their dedication to patient care, Alexion is actively involved in research and development. They continuously innovate through research partnerships and externally sponsored projects to advance new therapies.

Moreover, Alexion is committed to corporate social responsibility and actively gives back to the community, with initiatives like the Alexion Charitable Foundation and Managed Access Programs. Join their passionate and talented team to make a difference in the lives of families affected by rare diseases. Together, we can achieve remarkable breakthroughs and provide hope for a brighter future